Medicare Enrolled
Dr. Gregory Hoang, MD
Hematology & Oncology · Palm Bay, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hoang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hoang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hoang
Dr. Gregory Hoang is a hematology & oncology specialist in Palm Bay, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hoang performed 60,898 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hoang received a total of $33,242 from 99 pharmaceutical and/or device companies across 1381 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hoang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in FL
$33,242 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 73490 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗60,898
Medicare services
Top 13% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
15,750 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 15,420 | $18 | $70 |
| Pembrolizumab injection (Keytruda) | 11,000 | $43 | $147 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
8,100 | $0 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,760 | $0 | $3 |
| Iron infusion (Monoferric) | 1,900 | $17 | $74 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,190 | $1 | $122 |
| Anti-nausea injection (ondansetron/Zofran) | 640 | $0 | $4 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
520 | $8 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
490 | $64 | $180 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
357 | $22 | $152 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
347 | $98 | $224 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
332 | $100 | $686 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
265 | $8 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
261 | $11 | $93 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
178 | $55 | $270 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
171 | $2 | $19 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
144 | $22 | $156 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
137 | $49 | $304 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
135 | $12 | $105 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
116 | $1 | $7 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
108 | $25 | $249 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
92 | $63 | $157 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
84 | $50 | $334 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $124 | $420 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $135 | $3,938 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $23 | $141 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
45 | $3 | $15 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
44 | $103 | $297 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
41 | $16 | $97 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
35 | $62 | $330 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
28 | $18 | $111 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $81 | $230 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $29 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
31.0% high complexity
65.7% medium
3.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,242
Total received (2018-2024)
Avg $4,749/year across 7 years
Top 18% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,381
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,236
2023
$5,937
2022
$6,752
2021
$6,324
2020
$2,656
2019
$2,715
2018
$2,623
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$499
Merck Sharp & Dohme LLC
$464
PFIZER INC.
$398
Janssen Biotech, Inc.
$352
E.R. Squibb & Sons, L.L.C.
$336
GlaxoSmithKline, LLC.
$302
Novartis Pharmaceuticals Corporation
$235
Amgen Inc.
$232
Incyte Corporation
$230
Kite Pharma, Inc.
$220
Lilly USA, LLC
$216
GENZYME CORPORATION
$215
Alexion Pharmaceuticals, Inc.
$213
ABBVIE INC.
$175
Gilead Sciences, Inc.
$174
Celgene Corporation
$173
Pharmacosmos Therapeutics Inc.
$142
TAIHO ONCOLOGY, INC.
$124
Genentech USA, Inc.
$101
Astellas Pharma US Inc
$99
Eisai Inc.
$95
SOBI, INC
$92
Bayer Healthcare Pharmaceuticals Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$71
Sumitomo Pharma America, Inc.
$69
ARRAY BIOPHARMA INC
$68
Daiichi Sankyo Inc.
$64
PharmaEssentia USA Corporation
$56
Ipsen Biopharmaceuticals, Inc
$55
PUMA BIOTECHNOLOGY, INC.
$55
Karyopharm Therapeutics Inc.
$54
BeiGene USA, Inc.
$53
SERVIER PHARMACEUTICALS LLC
$49
JAZZ PHARMACEUTICALS INC.
$47
Regeneron Healthcare Solutions, Inc.
$46
Mirati Therapeutics, Inc.
$46
EMD Serono, Inc.
$46
SpringWorks Therapeutics, Inc.
$36
ADC Therapeutics America, Inc.
$35
TerSera Therapeutics LLC
$35
Dendreon Pharmaceuticals LLC
$34
Legend Biotech USA Inc.
$29
Genmab U.S., Inc.
$29
Exelixis Inc.
$20
Alnylam Pharmaceuticals Inc.
$19
Stemline Therapeutics Inc.
$17
Verity Pharmaceuticals Inc.
$15
Novocure Inc.
$14
Top 3 companies account for 21.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,238
E.R. Squibb & Sons, L.L.C.
$2,123
AstraZeneca Pharmaceuticals LP
$2,039
PFIZER INC.
$1,857
Amgen Inc.
$1,666
Janssen Biotech, Inc.
$1,520
Incyte Corporation
$1,382
Celgene Corporation
$1,295
Merck Sharp & Dohme LLC
$1,237
Astellas Pharma US Inc
$1,136
Genentech USA, Inc.
$1,114
Seagen Inc.
$1,020
GENZYME CORPORATION
$951
Daiichi Sankyo Inc.
$775
Lilly USA, LLC
$769
Regeneron Healthcare Solutions, Inc.
$571
GlaxoSmithKline, LLC.
$530
Merck Sharp & Dohme Corporation
$514
Kite Pharma, Inc.
$453
Takeda Pharmaceuticals U.S.A., Inc.
$444
Gilead Sciences, Inc.
$422
ABBVIE INC.
$352
Ipsen Biopharmaceuticals, Inc
$344
Eisai Inc.
$335
Pharmacyclics LLC, An AbbVie Company
$308
Exelixis Inc.
$299
JAZZ PHARMACEUTICALS INC.
$285
Pharmacosmos Therapeutics Inc.
$266
EISAI INC.
$259
Bayer HealthCare Pharmaceuticals Inc.
$257
Alexion Pharmaceuticals, Inc.
$256
BeiGene USA, Inc.
$241
Karyopharm Therapeutics Inc.
$238
Mirati Therapeutics, Inc.
$224
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
ARRAY BIOPHARMA INC
$189
EMD Serono, Inc.
$173
Novocure Inc.
$172
Janssen Products, LP
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
ADC Therapeutics America, Inc.
$166
Pharmacyclics LLC, an AbbVie Company
$147
Bayer Healthcare Pharmaceuticals Inc.
$142
MorphoSys, US Inc.
$140
TAIHO ONCOLOGY, INC.
$140
Kyowa Kirin, Inc.
$129
Seattle Genetics, Inc.
$126
AVEO Pharmaceuticals, Inc.
$122
SOBI, INC
$113
SANOFI-AVENTIS U.S. LLC
$100
Janssen Scientific Affairs, LLC
$95
Rigel Pharmaceuticals, Inc.
$90
Sumitomo Pharma America, Inc.
$88
Taiho Oncology, Inc.
$87
Global Blood Therapeutics, Inc.
$85
G1 Therapeutics, Inc.
$83
PharmaEssentia USA Corporation
$79
SERVIER PHARMACEUTICALS LLC
$73
PUMA BIOTECHNOLOGY, INC.
$68
TESARO, Inc.
$66
Clovis Oncology, Inc.
$65
Alnylam Pharmaceuticals Inc.
$61
TerSera Therapeutics LLC
$56
Helsinn Therapeutics (U.S.), Inc.
$56
Janssen Pharmaceuticals, Inc
$55
Puma Biotechnology, Inc.
$54
Myovant Sciences Inc.
$53
Heron Therapeutics, Inc.
$52
AbbVie, Inc.
$51
Epizyme, Inc.,
$51
Dova Pharmaceuticals
$48
Mylan Institutional Inc.
$47
Sobi, Inc
$40
Stemline Therapeutics Inc.
$39
EUSA Pharma (US) LLC
$38
SpringWorks Therapeutics, Inc.
$36
Dendreon Pharmaceuticals LLC
$34
Deciphera Pharmaceuticals Inc.
$30
Legend Biotech USA Inc.
$29
Genmab U.S., Inc.
$29
Verity Pharmaceuticals Inc.
$28
Acceleron Pharma, Inc.
$28
AMAG Pharmaceuticals, Inc.
$26
Apellis Pharmaceuticals, Inc.
$25
Fortovia Therapeutics, Inc.
$25
Sun Pharmaceutical Industries Inc.
$24
Blueprint Medicines Corporation
$24
TG THERAPEUTICS, INC.
$24
ACCORD HEALTHCARE, INC.
$20
Servier Pharmaceuticals LLC
$20
Emmaus Medical, Inc.
$20
AbbVie Inc.
$19
CTI BioPharma Corp.
$18
Advanced Accelerator Applications
$18
Agios Pharmaceuticals, Inc.
$15
Verastem, Inc.
$15
Octapharma USA, Inc.
$14
Sirtex Medical Inc
$11
Organon LLC
$10
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · FULPHILA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRBETRIQ · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · Soltamox · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Tecentriq Hybreza · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
18
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
PALM BAY HOSPITAL
8.5 mi
8.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hoang is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hoang experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Hoang performed 15,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hoang receive payments from pharmaceutical companies?
Yes. Dr. Hoang received a total of $33,242 from 99 companies across 1,381 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hoang's costs compare to other hematology & oncology specialists in Palm Bay?
Dr. Hoang's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hoang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Palm Bay
Browse hematology & oncology specialists in Palm Bay ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology